Title |
SIRT1 Activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating disease
|
---|---|
Published in |
Acta Neuropathologica Communications, January 2014
|
DOI | 10.1186/2051-5960-2-3 |
Pubmed ID | |
Authors |
Reas S Khan, Kimberly Dine, Jayasri Das Sarma, Kenneth S Shindler |
Abstract |
Multiple sclerosis (MS) is characterized by central nervous system inflammation and demyelination, and increasing evidence demonstrates significant neuronal damage also occurs and is associated with permanent functional impairment. Current MS therapies have limited ability to prevent neuronal damage, suggesting additional neuroprotective therapies are needed. Compounds that activate the NAD+-dependent SIRT1 deacetylase prevent neuronal loss in an autoimmune-mediated MS model, but the mechanism of this effect is unknown, and it is unclear whether SIRT1 activating compounds exert similar effects in demyelinating disease induced by other etiologies. We measured neuronal loss in C57BL/6 mice inoculated with a neurotropic strain of mouse hepatitis virus, MHV-A59, that induces an MS-like disease. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 2% |
Unknown | 48 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 8 | 16% |
Other | 5 | 10% |
Researcher | 5 | 10% |
Student > Master | 5 | 10% |
Student > Bachelor | 3 | 6% |
Other | 12 | 24% |
Unknown | 11 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 14 | 29% |
Biochemistry, Genetics and Molecular Biology | 8 | 16% |
Medicine and Dentistry | 5 | 10% |
Neuroscience | 4 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 4% |
Other | 2 | 4% |
Unknown | 14 | 29% |